- Home
- ALTO vs PLRX Comparison
ALTO vs PLRX Comparison
Compare ALTO & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTO
- PLRX
- Stock Information
- Founded
- ALTO 2003
- PLRX 2015
- Country
- ALTO United States
- PLRX United States
- Employees
- ALTO N/A
- PLRX N/A
- Industry
- ALTO Major Chemicals
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- ALTO Industrials
- PLRX Health Care
- Exchange
- ALTO Nasdaq
- PLRX Nasdaq
- Market Cap
- ALTO 90.6M
- PLRX 89.0M
- IPO Year
- ALTO N/A
- PLRX 2020
- Fundamental
- Price
- ALTO $1.18
- PLRX $1.53
- Analyst Decision
- ALTO Strong Buy
- PLRX Hold
- Analyst Count
- ALTO 1
- PLRX 10
- Target Price
- ALTO $5.50
- PLRX $3.93
- AVG Volume (30 Days)
- ALTO 165.7K
- PLRX 725.5K
- Earning Date
- ALTO 11-05-2025
- PLRX 11-06-2025
- Dividend Yield
- ALTO N/A
- PLRX N/A
- EPS Growth
- ALTO N/A
- PLRX N/A
- EPS
- ALTO N/A
- PLRX N/A
- Revenue
- ALTO $933,137,000.00
- PLRX N/A
- Revenue This Year
- ALTO N/A
- PLRX N/A
- Revenue Next Year
- ALTO $7.53
- PLRX N/A
- P/E Ratio
- ALTO N/A
- PLRX N/A
- Revenue Growth
- ALTO N/A
- PLRX N/A
- 52 Week Low
- ALTO $0.76
- PLRX $1.10
- 52 Week High
- ALTO $2.05
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- ALTO 61.82
- PLRX 44.68
- Support Level
- ALTO $1.14
- PLRX $1.66
- Resistance Level
- ALTO $1.10
- PLRX $1.85
- Average True Range (ATR)
- ALTO 0.05
- PLRX 0.13
- MACD
- ALTO 0.01
- PLRX -0.02
- Stochastic Oscillator
- ALTO 76.92
- PLRX 12.20
About ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, Western production, and Others.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.